Background {#Sec1}
==========

Trauma triage guidelines are typically based on injury mechanism, injuries identified and vital signs reported. Reliance on vital signs and physical exam however, has been reported to miss patients with serious injury \[[@CR1]\]. Point of care (POCT) serum lactate measurement is emerging as an adjunct to pre-hospital clinical assessment and has the potential to guide triage and advanced treatment decision-making: pre-hospital lactate levels have been shown to predict the need for resuscitative in-hospital care in trauma patients \[[@CR2]--[@CR5]\], and to predict outcome of trauma patients \[[@CR6]\].

Historically, lactate formation in trauma patients was thought to originate from anaerobic glycolysis: hemorrhage and inadequate ventilation following a traumatic injury can lead to hypovalemia, hypoxaemia and end-organ hypoperfusion, resulting in anaerobic glycolysis and lactate formation. Over the past decade however, it has become clear that (beta adrenergic mediated) accelerated aerobic glycolysis is a major contributor to lactate formation under various conditions as well \[[@CR7]\]. This is important to realize, as beta adrenergic stimulation in pre-hospital trauma patients is almost universally present as a result from pain and/or stress. Furthermore, many pharmacological and non-pharmacological) treatments on scene have the potential to modulate beta adrenergic stimulation, and thereby influence lactate levels. Although this will not affect the prognostic ability of elevated prehospital lactate levels as such (several studies have shown that the prognostic ability of lactate exceeds the prognostic ability of markers of end organ hypoperfusion) \[[@CR2]--[@CR5]\], it might influence the use of lactate as a marker to guide advanced prehospital treatments such as blood product transfusion \[[@CR8]\].

Therefore, this study aims to examine which patient- and treatment factors are related to POCT lactate levels in prehospital trauma patients.

Methods {#Sec2}
=======

Study design and subjects {#Sec3}
-------------------------

We performed a retrospective study of all trauma patients attended by Air Ambulance Kent, Surrey Sussex (AAKSS) between July 2017 (when lactate measurements became available to the service) and April 2018 (when the study protocol was completed). All patients in whom a pre-hospital lactate levels was measured, irrespective of their age, injury type, injury severity or outcome were included. Consecutive patients with non-traumatic pathology in whom a lactate was measured were excluded.

Setting {#Sec4}
-------

AAKSS is a helicopter emergency medical service (HEMS) covering three counties in the southeast of England with a resident population of 4.5 million and transient population of up to 8 million. Two doctor/paramedic teams respond in helicopters or rapid response cars from one base and the service attends approximately 2000 patients per year. Most patients attended by the HEMS service are first seen by a ground ambulance crew and/or a critical care paramedic.

Lactate measurement {#Sec5}
-------------------

Prehospital lactate measurements became available to AAKSS HEMS teams as an adjunct to clinical assessment in July 2017 using the NOVA StatStrip® Biomedical Xpress™ Point of care (POCT) Lactate Meter system \[[@CR9], [@CR10]\]. Current AAKSS Standard Operating Procedures (SOP), recommend lactate measurement in all patients with suspected major hemorrhage. Lactate was measured from venous blood, drawn in a 2 ml syringe during venapuncture or after insertion of an intravenous canula. Lactate was drawn and analyzed in the prehospital setting before EMS treatments (including transfusion of any blood products) was commenced, but generally after prehospital treatment by ground ambulance crews (such as circulatory support, analgesia, and haemostatic interventions) was initiated.

Outcome measures {#Sec6}
----------------

The primary outcome measure in this study was defined as the association of various patient- and treatment characteristics with (elevated) prehospital lactate levels. In accordance with previous studies \[[@CR11], [@CR12]\], elevated lactate was defined as a blood concentration \> 2.5 mmol/l.

Data acquisition {#Sec7}
----------------

Patient demographics, mechanism- and nature of injuries, vital signs, POCT test results (including lactate), and treatments provided by the HEMS team and other EMS services are recorded by clinical crews in a dedicated electronic patient record (HEMSbase 2.0, Medic One Systems Ltd., UK). Data were retrieved from this electronic recorded for the purpose of this study, using a standardized proforma (See Supplementary file [1](#MOESM1){ref-type="media"}).

Ethics {#Sec8}
------

This project met National Institute for Healthcare Research (NIHR, UK) criteria for service evaluation and ethical review was therefore not conducted by an external body (such as an NHS research Ethics Committee \[[@CR13]\]. All the data used for this study were routinely collected as part of standard prehospital and hospital patient data collection. The project was approved by the AAKSS Research & Development Committee. The study has been performed in accordance with the ethical standards laid down in the Declaration of Helsinki.

Patient and public involvement {#Sec9}
------------------------------

It was not appropriate or possible to involve patients or the public in the design, or conduct, or reporting, or dissemination of our research.

Statistical analysis {#Sec10}
--------------------

Shapiro Wilk tests were performed to assess normal distribution, and residual plots were drawn to assess linearity of data. Descriptive statistics are given as numbers \[%\] or median \[interquartile range, IQR\]. Comparisons across groups were made using Fisher's exact test and Mann-Whitney U test where appropriate. Univariate correlation analysis with calculation of Spearman correlation coefficients was performed to evaluate the correlation of clinical- and treatment factors with the primary outcome (lactate). Stepwise multivariable regression analyses including factors with a significant correlation was performed to determine which factors were independently related to the primary outcome measure. Missing values are reported in the results section of the manuscript according to the STROBE guideline \[[@CR14]\]. A *p*-value \< 0.05 was regarded as statistically significant. All statistical analyses were conducted using IBM SPSS 23.0 for Apple statistical package (SPSS Inc., Chicago, Illinois, USA) and VassarStats online statistical software ([Vassarstats.net](http://vassarstats.net)).

Results {#Sec11}
=======

Study population {#Sec12}
----------------

During the study period, 1188 patients were seen by AAKSS. A prehospital lactate was obtained in 174 patients (14.6%). Eighteen patients were excluded as they were attended by HEMS for a medical (non-trauma) reason (supplementary file [1](#MOESM1){ref-type="media"}). Subsequent results refer to the remaining 156 trauma patients (13.1%). The majority of the patients were male (79.5%), and involved in road traffic collisions (blunt trauma mechanism, 89.7%). The average time from 999-call to drawing blood for a lactate sample was 66 \[46--87\] minutes. Injuries, vital signs upon arrival of HEMS, and treatments provided by the HEMS team or other emergency medical services before blood was drawn to determine lactate, are described in Table [1](#Tab1){ref-type="table"}. Table 1Study population characteristicsAll (*n* = 156)Lactate \< 2.5 mmol/L (*n* = 61)Lactate \> 2.5 mmol/L (*n* = 95)*p*missing**Biometric data** Age (y)44 \[24--64\]44 \[23--66\]45 \[27--63\].642 Male Gender (n,%)124 \[79.5\]48 \[78.7\]76 \[80\].842**Injury characteristics** Mechanism  Blunt trauma (n,%)140 \[89.7\]56 \[91.8\]84 \[88.4\].595  Sharp trauma (n,%)16 \[10.3\]5 \[8.2\]11 \[11.6\].595 Body regions affected  Head (n,%)84 \[53.8\]25 \[41.0\]59 \[62.1\].0082  Chest (n,%)73 \[46.8\]31 \[50.8\]42 \[45.2\].5132  Abdomen (n,%)72 \[46.2\]29 \[47.5\]43 \[45.3\].870  Limb (n,%)75 \[48.1\]29 \[47.5\]46 \[48.4\].990 Nr of regions affected (n)2 \[0--4\]2 \[0--4\]2 \[0--4\].373**Lactate** 999-lactate sample (min)66 \[46--87\]62 \[45--80\]67 \[46--88\].42033 Lactate (mmol/l)3.0 \[2.0--4.1\]1.8 \[0.5--2.2\]3.8 \[2.7--4.9\]\<.001**Indices of end organ perfusion and oxygenation** Palpable radial pulse \[y\]138 \[88.5\]58 \[95.1\]80 \[84.2\].042 SBP (mmHg)129 \[109--149\]134 \[117--152\]123 \[102--144\].00110 HR (bpm)88 \[66--110\]85 \[64--106\]96 \[75--117\].02314 Shock index.72 \[.51--.93\].61 \[.40--.82\].80 \[.58--1.03\]\<.00114 EtCO~2~ (kPa)4.1 \[3.5--5.4\]4.1 \[2.0--6.0\]4.0 \[3.2--4.8\].39044 SpO~2~ (%)97 \[93--100\]98 \[96--100\]96 \[89--100\].02516**Treatments before HEMS** Circ and resp. support  Adrenaline6 \[3.8\]1 \[1.6\]5 \[5.3\].405  IV fluids14 \[9.0\]2 \[3.3\]12 \[12.6\].050 Pain relieving interventions  IVP and/or morphine87 \[55.8\]41 \[67.2\]49 \[51.6\].031   IVP61 \[39.1\]30 \[49.2\]31 \[32.6\].045   morphine51 \[32.7\]23 \[37.7\]28 \[29.5\].299  Reduction or splinting^a^29 \[18.6\]8 \[13.1\]21 \[22.1\].207 Haemostatic interventions  Pelvic splint76 \[48.7\]28 \[45.9\]48 \[50.5\].624  Compression Bandage or tourniquet14 \[9.0\]7 \[11.5\]7 \[7.4\].402  TXA75 \[48.1\]26 \[42.6\]49 \[51.6\].325*Footnote***:** Continuous data represented as n \[%\], nominal data as median \[IQR\]. ^a^manual reduction of fracture or dislocation and/or Kendrick and/or vacuum splint application. *SBP* Systolic blood pressure, *HR* Heart rate, *EtCO*~*2*~ End tidal CO~2~, *SpO*~*2*~ Percentage oxygen saturation, *IV* Intravenous, *IVP* Intravenous paracetamol, *TXA* Tranexamic acid.

Correlation of patient- and treatment characteristics with lactate levels {#Sec13}
-------------------------------------------------------------------------

Injury type was related to (elevated) lactate levels: Patients with head injury more often had elevated lactate levels (41% vs. 62%, *p* \< 0.008, Table [1](#Tab1){ref-type="table"}), and head injury was correlated to lactate levels (r = 0.22, *p* = 0.006, Table [2](#Tab2){ref-type="table"}). As expected from previous studies, lactate levels were related to markers of end-organ perfusion- and oxygenation (radial pulse, heart rate \[HR\], systolic blood pressure \[SBP\], Shock index \[SI\], Oxygen saturation (SpO~2~) and end-tidal CO~2~ \[EtCO~2\]~) (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). SI demonstrated the highest correlation with lactate levels (r = 0.35, *p* \< 0.001). Several treatment factors were related to lactate levels: iv fluid administration showed a (weak) positive correlation with lactate levels, whereas administration of IV analgesia, showed an inverse relation with both absolute- and elevated lactate levels (Table [2](#Tab2){ref-type="table"}). Table 2Univariate correlation coefficients of patient characteristics with pre-hospital lactate levels in trauma patients attended by HEMS (*n* = 156)Lactate (mmol/l)Lactate \> 2.5 mmol/lr \[95%CI\]*p*r \[95% CI\]*p***Biometric data** Age (y).01 \[−.15--.16\].974−.04 \[−.24--.17\].643 Gender (n,%male)−.03 \[−.18--13\].758−.02 \[−.17--.14\].844**Injury/disease characteristics** Mechanism.09 \[−.07--.25\].255.05 \[−.10--.21\].500 Nr Body regions affected.11 \[−.05--.26\].176.10 \[−.06--25\].220  Head (n,%).22 \[.07--.37\].006.22 \[.07--.37\].006  Chest (n,%).01 \[−.15--.16\].950−.06 \[−.21--.10\].495  Abdomen (n,%)−.03 \[−.19--.13\].718−.02 \[−.18--.14\].782  Limb (n,%)−.03 \[−.19--.13\].688.01 \[−.15--.17\].915 999-lactate sample (min).12 \[−.04--.27\].197.07 \[−.09--.23\].422**Indices of end-organ perfusion and oxygenation** Palpable radial pulse \[y\]−.29 \[−.42\--.14\]\<.001−.17 \[−.31\--.01\].038 SBP (mmHg)−.31 \[−.44\--.16\]\<.001−.28 \[−.42\--.13\].001 HR (bpm).21 \[.06--.36\].011.19 \[−.34--0.03\].023 Shock index.35 \[.20--.48\]\<.001.34 \[.19--.47\]\<.001 First EtCO~2~ (kPa)−.16 \[−.31--.01\].101−.08 \[−.24--.08\].392 SpO~2~−.24 \[−.38\--.08\].005−.19 \[−.34\--.03\].024**Treatments before HEMS** Circ and resp. support  Adrenalin.11 \[−.04--.27\].155.09 \[−.06--.25\].254  IV fluids.17 \[.01--.31.040.16 \[.01--.31\].046 Pain relieving interventions  IVP and/or morphine−.24 \[−.38\--.09\].003−.19 \[−.33\--.03\].021   IVP−.18 \[−.32\--.02\].027−.17 \[−.31\--.01\].039   Morphine−.16 \[−.31--.01\].040−.09 \[−.24--.07\].288  Reduction or splinting^a^.10 \[−.06--.25\].227.11 \[−.04--.27\].161 Haemostatic interventions  Pelvic splint.05 \[−.10--.21\].502.05 \[−.11--.20\].576  Compression bandage or tourniquet−.12 \[−.27--.01.126−.07 \[−.22--.09\].384  TXA.12 \[−.04--.27\].147.09 \[−.07--.24\].278*Footnote*: ^a^Manual reduction of fracture or dislocation and/or Kendrick and/or vacuum splint application. *SBP* Systolic blood pressure, *HR* Heart rate, *EtCO*~*2*~ End tidal CO~2~, *SpO*~*2*~ Percentage oxygen saturation, *IV* Intravenous, *IVP* Intravenous paracetamol, *TXA* Tranexamic acid

In multivariate analysis, SpO~2~, SI and IV analgetic administration prior to HEMS arrival remained independently associated with prehospital lactate, together explaining 17.7% of the variation in lactate levels (Table [3](#Tab3){ref-type="table"}). Indices of end-organ perfusion and oxygenation (SpO2 and SI) were responsible for 15% of the variation in lactate levels. Sensitivity analysis revealed that within the subgroup of patients with a head injury (*n* = 76) SpO2 and SI predicted a similar percentage (17%) of the variation in lactate levels. Table 3Patient- and treatment characteristics of trauma patients associated with prehospital lactate levels (*n* = 156)VariableSt ßAdjusted R^2a^*P*First measured SpO2−.271.112.001Shock Index.187.039.023IVP or Morphine−.184.026.024Head Injury \[y/n\]NANANA*Footnote*. To avoid problems with co-linearity, Shock index was chosen over SBP, HR and palpable radial pulse in the regression model. ^a^denotes absolute increase in R^2^ when entered in the model. *NA* Did not enter final model, *SpO*~*2*~ Percentage oxygen saturation, *IVP* Intravenous paracetamol, *EtCO*~*2*~ End-tidal CO~2~, *TBI* Traumatic brain injury.

Discussion {#Sec14}
==========

As expected, indices of end-organ perfusion- and oxygenation are associated with (elevated) lactate levels in prehospital trauma patients. However, these factors explained only 15% of the variation in prehospital lactate levels. Therefore, it is likely that other (independent) processes were responsible for lactate production- and clearance in these patients as well.

First, catecholamine release as a result of pain, stress or increased metabolic demand can result in lactate formation by activating intracellular cAMP, resulting in accelerated aerobic glycolysis \[[@CR15], [@CR16]\]. As trauma patients invariably have pain and/or stress, this is a likely contributor to pre-hospital lactate levels. We haven't been able to quantify this directly in our study. However, it is well known that adequate analgesia blunts the physiological stress response and limits endogeneous catecholamine release, resulting in a decreased rate of glycolysis \[[@CR17]\]. This is in agreement with the inverse relation between IV analgesic administration and lactate levels as found in this study.

Second, supportive treatments such as sodium chloride 0.9% or adrenaline administration, initiated before a blood sample for lactate measurement is drawn, may moderate HR, SBP, SI, and SpO~2~, and thereby influence tissue perfusion. The effect on lactate levels however, is more difficult to predict, as improved tissue perfusion may result in increased shuttling of lactate throughout the body \[[@CR18]\]. This may have contributed to the (weak) positive association of fluid administration with elevated lactate levels as found in this study, although the effect of confounding by indication (sicker patients receiving more fluids) might have played a role as well.

Third, isolated injuries may result in elevated blood lactate levels, whereas their influence on indices of end organ perfusion- or oxygenation may be limited. Examples of these injuries are traumatic amputation \[[@CR19]\] or isolated traumatic brain injury (TBI) \[[@CR20]\]. Previous studies have shown that glia cells in the brain increase lactate production purposely in order to meet the increased metabolic demand of adjacent neurons during TBI \[[@CR21]\]. This is in agreement with the association we found between head injured patients and (elevated) lactate levels in this study. As a significant interaction was also present between "head injury" and the administration of IV analgesics however, head injury did not contribute to the amount of explained variance in lactate levels in the multivariate model.

Furthermore, lactate levels measured at any point in time are not only the result of lactate production, but also of lactate clearance and utilization \[[@CR15]\]. The liver takes up lactate from the blood, where it is reconverted to glucose in the Cori Cycle. Lactate can also be taken up by various tissues (brain, heart, muscle) and be directly utilized. Clearance is affected by various factors, including alcohol consumption (dose dependent decrease \[[@CR22]\]) and (liver) tissue patency. Many of these are unknown to the clinicians caring for the patient in the prehospital situation.

In our study we observed that pre-hospital lactate levels not only represent end-organ perfusion, but also other processes, as the adrenergic response of the body to injuries and the adequacy of the initiated treatment(s). Elevated prehospital lactate levels should therefore not simply be considered as a marker of end organ hypoperfusion- or oxygenation. Although lactate levels were related to HR, SBP and SI in this study, correlation coefficients were low, especially compared to previously published in-hospital studies \[[@CR23], [@CR24]\]. The difference with in-hospital studies may be explained by the likelihood of the presence of a time lag between deterioration of vital signs and increased lactate formation and/or decreased lactate clearance. For in-hospital patients this argument may be less important, as sufficient time since the injury will have passed to ensure both lactate and vital signs are deranged.

Our study has some limitations, most of them inherent to the retrospective design. Firstly, the reported associations do not necessarily represent causality (as selection by indication might have been present for treatment factors as analgesics administration). This study should therefore mainly be regarded as hypothesis generating. Prospective studies are warranted to confirm our findings, especially regarding the effect of treatment factors on lactate, as there is an inherent risk of confounding by indication when considering the relation between lactate and treatment factors. Second, this study was done in a convenience sample of trauma patients in whom a lactate was measured, and cannot be extrapolated to the wider population of all prehospital trauma patients. Furthermore, although overall data completeness was good due to the use of our electronic patient record, there were missing data for some variables. Furthermore, as lactate samples were drawn before HEMS treatments (such as transfusion of blood products or RSI) were commenced, it is unclear how these advanced treatments would be related to lactate levels.

Finally, only single lactate measurements were available. Previous studies in other populations have shown that serial measurements improve not only prognostication, but might be helpful to guide treatment as well \[[@CR25]\].

Conclusion {#Sec15}
==========

Prehospital lactate levels are not solely associated with indices of end organ perfusion- and oxygenation. Injury type, treatments given on scene and many other (unmeasured) factors likely play an important role as well. This should be taken into account when lactate is used in clinical algorithms to guide prehospital triage or treatment.
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AAKSS

:   Air Ambulance Kent, surrey and Sussex

HEMS

:   Helicopter Emergency medical service

POCT

:   Point-of-care testing

SOP

:   Standard operating procedure
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